Hoxhaj et al in 2020, found that GSTM1, GSTT1 and GSTP1 polymorphisms might increase the risk of developing a second primary cancer among head and neck cancer survivors in different degrees.[21] However, because of the bias of language expression, regions, source and number of cases, there is still lack of a consistent conclusion. The gene discussed is GSTM1; the disease is cancer.